---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-018926"
form_type: "8-K"
ticker: "LUCD"
cik: "0001799011"
company_name: "Lucid Diagnostics Inc."
filed_at: "2026-04-24T23:59:59+00:00"
generated_at: "2026-05-15T04:13:27.467137+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Lucid Diagnostics closes $18M underwritten offering of 18M shares at $1.00/share

## Summary
- Closed sale of 18,000,000 shares at $1.00/share; gross proceeds $18M, net proceeds ~$16.8M.
- Net proceeds to be used for working capital and general corporate purposes.
- Joint bookrunners: Canaccord Genuity LLC and BTIG, LLC.
- Offering anchored by $15M investment from fundamental institutional investor and support from a large existing shareholder.
- Offered under effective shelf registration statement on Form S-3 declared effective March 26, 2026.

## SEC filing metadata
- accession: 0001493152-26-018926
- form_type: 8-K
- ticker: LUCD
- cik: 0001799011
- company_name: Lucid Diagnostics Inc.
- filed_at: 2026-04-24T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799011/000149315226018926/0001493152-26-018926-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799011/000149315226018926/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-018926
- JSON: https://secwatch.observer/filing/0001493152-26-018926.json
- Plain text: https://secwatch.observer/filing/0001493152-26-018926.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
